Company’s first metered-dose inhalation (MDI) product and establishes a new growth vector for the Affordable Medicines segment BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal ...
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...
New Delhi: What began as a routine complaint of nasal blockage turned into one of the most extraordinary medical cases doctors at Manipal Hospital, Dwarka, ever encountered. A 33-year-old woman, ...
Oticara, an emerging pharmaceutical company advancing physician-delivered treatments for chronic rhinosinusitis (CRS), today announced that new late-breaking clinical data from its Phase 2 OT-007B ...
Objective: To develop a Sustained Adherence Behavior Model for inhaled corticosteroids (ICS) Medication in Children with Asthma. Method: Through literature review and semi-structured interviews, a ...
Azelastine nasal spray has been available for decades as an over-the-counter treatment for hay fever. A common nasal spray used for allergies may help prevent Covid-19, according to a new study from ...